Lithium inhibits tumor lymphangiogenesis and metastasis through the inhibition of TGFBIp expression in cancer cells

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Maeng, Yong Sun ^a   Lee, Rina ^a   Lee, Boram ^a   Choi, Seung Il ^a   Kim, Eung Kweon ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETAIG-H3 PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; GSK3B PROTEIN, MOUSE; LITHIUM; SCLEROPROTEIN; SMAD3 PROTEIN; SMAD3 PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR BETA; TUMOR PROTEIN;

ANIMAL; BIOSYNTHESIS; COLONIC NEOPLASMS; DRUG EFFECTS; GENE EXPRESSION REGULATION; LYMPHANGIOGENESIS; METABOLISM; METASTASIS; MOUSE; PATHOLOGY; PHOSPHORYLATION; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; COLONIC NEOPLASMS; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOGEN SYNTHASE KINASE 3 BETA; LITHIUM; LYMPHANGIOGENESIS; MICE; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PHOSPHORYLATION; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 84957818565     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep20739     Document Type: Article

References (51)

1. Edge, S. B. & Compton, C. C. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Annals of surgical oncology 17, 1471-1474 (2010).
2. Gallagher, D. J. & Kemeny, N. Metastatic colorectal cancer: from improved survival to potential cure. Oncology 78, 237-248 (2010).
3. Wanebo, H. J. et al. Meeting the biologic challenge of colorectal metastases. Clin Exp Metastasis 29, 821-839 (2012).
4. Shamloo, B. K., Chhabra, P., Freedman, A. N., Potosky, A., Malin, J. & Weiss Smith, S. Novel adverse events of bevacizumab in the US FDA adverse event reporting system database: a disproportionality analysis. Drug Saf 35, 507-518 (2012).
5. Schoppmann, S. F. et al. Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg 240, 306-312 (2004).
6. Stacker, S. A., Baldwin, M. E. & Achen, M. G. The role of tumor lymphangiogenesis in metastatic spread. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 16, 922-934 (2002).
7. Sleeman, J. P. & Thiele, W. Tumor metastasis and the lymphatic vasculature. International journal of cancer Journal international du cancer 125, 2747-2756 (2009).
8. Maeng, Y. S., Aguilar, B., Choi, S. I. & Kim, E. K. Inhibition of TGFBIp expression reduces lymphangiogenesis and tumor metastasis. Oncogene (2015).
9. Liang, M. H. & Chuang, D. M. Differential roles of glycogen synthase kinase-3 isoforms in the regulation of transcriptional activation. The Journal of biological chemistry 281, 30479-30484 (2006).
10. Derynck, R. & Zhang, Y. E. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425, 577-584 (2003).
11. Shi, Y. & Massague, J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113, 685-700 (2003).
12. Hedgepeth, C. M., Conrad, L. J., Zhang, J., Huang, H. C., Lee, V. M. & Klein, P. S. Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Developmental biology 185, 82-91 (1997).
13. Phiel, C. J. & Klein, P. S. Molecular targets of lithium action. Annu Rev Pharmacol Toxicol 41, 789-813 (2001).
14. Stambolic, V., Ruel, L. & Woodgett, J. R. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Current biology: CB 6, 1664-1668 (1996).
15. Klein, P. S. & Melton, D. A. A molecular mechanism for the effect of lithium on development. Proceedings of the National Academy of Sciences of the United States of America 93, 8455-8459 (1996).
16. Fukumoto, T., Morinobu, S., Okamoto, Y., Kagaya, A. & Yamawaki, S. Chronic lithium treatment increases the expression of brainderived neurotrophic factor in the rat brain. Psychopharmacology (Berl) 158, 100-106 (2001).
17. Gould, T. D. & Manji, H. K. The Wnt signaling pathway in bipolar disorder. Neuroscientist 8, 497-511 (2002).
18. Chalecka-Franaszek, E. & Chuang, D. M. Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proceedings of the National Academy of Sciences of the United States of America 96, 8745-8750 (1999).
19. De Sarno, P., Li, X. & Jope, R. S. Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium. Neuropharmacology 43, 1158-1164 (2002).
20. Zhang, F., Phiel, C. J., Spece, L., Gurvich, N. & Klein, P. S. Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3. The Journal of biological chemistry 278, 33067-33077 (2003).
21. Gould, T. D., Quiroz, J. A., Singh, J., Zarate, C. A. & Manji, H. K. Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers. Mol Psychiatry 9, 734-755 (2004).
22. Jope, R. S. Anti-bipolar therapy: mechanism of action of lithium. Mol Psychiatry 4, 117-128 (1999).
23. Kirshenboim, N., Plotkin, B., Shlomo, S. B., Kaidanovich-Beilin, O. & Eldar-Finkelman, H. Lithium-mediated phosphorylation of glycogen synthase kinase-3beta involves PI3 kinase-dependent activation of protein kinase C-alpha. J Mol Neurosci 24, 237-245 (2004).
24. Liang, M. H. & Chuang, D. M. Regulation and function of glycogen synthase kinase-3 isoforms in neuronal survival. The Journal of biological chemistry 282, 3904-3917 (2007).
25. Choi, S. I. et al. Inhibition of TGFBIp expression by lithium: implications for TGFBI-linked corneal dystrophy therapy. Investigative ophthalmology & visual science 52, 3293-3300 (2011).
26. Hewitt, R. E. et al. Validation of a model of colon cancer progression. The Journal of pathology 192, 446-454 (2000).
27. Li, H. et al. Lithium chloride suppresses colorectal cancer cell survival and proliferation through ROS/GSK-3beta/NF-kappaB signaling pathway. Oxid Med Cell Longev 2014, 241864 (2014).
28. Peng, Z., Ji, Z., Mei, F., Lu, M., Ou, Y. & Cheng, X. Lithium inhibits tumorigenic potential of PDA cells through targeting hedgehog-GLI signaling pathway. PloS one 8, e61457 (2013).
29. Choi, S. I. et al. Impaired autophagy and delayed autophagic clearance of transforming growth factor beta-induced protein (TGFBI) in granular corneal dystrophy type 2. Autophagy 8, 1782-1797 (2012).
30. Guo, X., Ramirez, A., Waddell, D. S., Li, Z., Liu, X. & Wang, X. F. Axin and GSK3-control Smad3 protein stability and modulate TGF-signaling. Genes & development 22, 106-120 (2008).
31. Mandriota, S. J. et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. The EMBO journal 20, 672-682 (2001).
32. Skobe, M. et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nature medicine 7, 192-198 (2001).
33. Ueda, M. et al. Vascular endothelial growth factor-C expression and invasive phenotype in ovarian carcinomas. Clinical cancer research: an official journal of the American Association for Cancer Research 11, 3225-3232 (2005).
34. Okudera, K. et al. Small adenocarcinoma of the lung: prognostic significance of central fibrosis chiefly because of its association with angiogenesis and lymphangiogenesis. Pathology international 56, 494-502 (2006).
35. Kitadai, Y. Angiogenesis and lymphangiogenesis of gastric cancer. J Oncol 2010, 468725 (2010).
36. Bruyere, F. & Noel, A. Lymphangiogenesis: in vitro and in vivo models. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 24, 8-21 (2010).
37. Nathanson, S. D. Insights into the mechanisms of lymph node metastasis. Cancer 98, 413-423 (2003).
38. Nowicki, M. O. et al. Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3. Neuro Oncol 10, 690-699 (2008).
39. Vidal, F., de Araujo, W. M., Cruz, A. L., Tanaka, M. N., Viola, J. P. & Morgado-Diaz, J. A. Lithium reduces tumorigenic potential in response to EGF signaling in human colorectal cancer cells. International journal of oncology 38, 1365-1373 (2011).
40. Ronchi, A. et al. Lithium induces mortality in medulloblastoma cell lines. International journal of oncology 37, 745-752 (2010).
41. Erdal, E., Ozturk, N., Cagatay, T., Eksioglu-Demiralp, E. & Ozturk, M. Lithium-mediated downregulation of PKB/Akt and cyclin E with growth inhibition in hepatocellular carcinoma cells. International journal of cancer Journal international du cancer 115, 903-910 (2005).
42. Beyaert, R., Vanhaesebroeck, B., Suffys, P., Van Roy, F. & Fiers, W. Lithium chloride potentiates tumor necrosis factor-mediated cytotoxicity in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America 86, 9494-9498 (1989).
43. Cohen, Y., Chetrit, A., Cohen, Y., Sirota, P. & Modan, B. Cancer morbidity in psychiatric patients: influence of lithium carbonate treatment. Medical oncology 15, 32-36 (1998).
44. Zhu, Z. et al. Lithium suppresses astrogliogenesis by neural stem and progenitor cells by inhibiting STAT3 pathway independently of glycogen synthase kinase 3 beta. PloS one 6, e23341 (2011).
45. Kaufmann, L. et al. LiCl induces TNF-alpha and FasL production, thereby stimulating apoptosis in cancer cells. Cell Commun Signal 9, 15 (2011).
46. Mao, C. D., Hoang, P. & DiCorleto, P. E. Lithium inhibits cell cycle progression and induces stabilization of p53 in bovine aortic endothelial cells. The Journal of biological chemistry 276, 26180-26188 (2001).
47. Johnson, G. & Gershon, S. Early North American research on lithium. Aust N Z J Psychiatry 33 Suppl, S48-53 (1999).
48. Kotliarova, S. et al. Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation. Cancer research 68, 6643-6651 (2008).
49. Marchand, B., Tremblay, I., Cagnol, S. & Boucher, M. J. Inhibition of glycogen synthase kinase-3 activity triggers an apoptotic response in pancreatic cancer cells through JNK-dependent mechanisms. Carcinogenesis 33, 529-537 (2012).
50. Shimasaki, T. et al. Glycogen synthase kinase 3beta inhibition sensitizes pancreatic cancer cells to gemcitabine. J Gastroenterol 47, 321-333 (2012).
51. Schotte, P., Van Loo, G., Carpentier, I., Vandenabeele, P. & Beyaert, R. Lithium sensitizes tumor cells in an NF-kappa B-independent way to caspase activation and apoptosis induced by tumor necrosis factor (TNF). Evidence for a role of the TNF receptor-associated death domain protein. The Journal of biological chemistry 276, 25939-25945 (2001).